Severe thrombocytopenia and excellent response following combined immune checkpoint inhibition for metastatic malignant melanoma

被引：2
|
作者：
Wang, R. [1 ]
Uretzki, M. [1 ]
Boehmer, D. [1 ]
Hein, R. [1 ]
Biedermann, T. [1 ]
Posch, C. [1 ]
机构：
[1] Tech Univ Munich, Dept Dermatol & Allergy Biederstein, Munich, Germany
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2021年 / 35卷 / 01期
关键词：
D O I：
10.1111/jdv.16829
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E89 / E92
页数：12
相关论文
共 50 条
  • [1] Response to Treatment for metastatic malignant Melanoma under double Immune Checkpoint Blockade
    Steimke, L.
    Rodig, M.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 : 15 - 15
  • [2] Prognostic Hematologic Biomarkers Following Immune Checkpoint Inhibition in Metastatic Uveal Melanoma
    Waninger, Jessica J. J.
    Fecher, Leslie A. A.
    Lao, Christopher
    Yentz, Sarah
    Green, Michael D. D.
    Demirci, Hakan
    CANCERS, 2022, 14 (23)
  • [3] Is "Cure" possible in metastatic Melanoma by Immune Checkpoint Inhibition
    Koett, Julian
    Hildebrandt, Lina
    Heidrich, Isabel
    Geidel, Glenn
    Hansen, Inga
    Schneider, StefanW.
    Gebhardt, Christoffer
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 164 - 165
  • [4] Neoadjuvant Immune Checkpoint Inhibition in Metastatic Conjunctival Melanoma
    Fan, Kelly
    Waninger, Jessica J.
    Yentz, Sarah
    McLean, Scott
    Demirci, Hakan
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2023, 39 (05): : E152 - E155
  • [5] Response to BRAF Inhibition in Melanoma Is Enhanced When Combined with Immune Checkpoint Blockade
    Cooper, Zachary A.
    Juneja, Vikram R.
    Sage, Peter T.
    Frederick, Dennie T.
    Piris, Adriano
    Mitra, Devarati
    Lo, Jennifer A.
    Hodi, Stephen
    Freeman, Gordon J.
    Bosenberg, Marcus W.
    McMahon, Martin
    Flaherty, Keith T.
    Fisher, David E.
    Sharpe, Arlene H.
    Wargo, Jennifer A.
    CANCER IMMUNOLOGY RESEARCH, 2014, 2 (07) : 643 - 654
  • [6] Combined Immune Checkpoint Inhibition in an inoperable Gingival Melanoma
    Neumann, M.
    Ruppel, E.
    Unger, S.
    Zahn, A.
    Ludwig-Peitsch, W. K.
    AKTUELLE DERMATOLOGIE, 2019, 45 (04) : 167 - 171
  • [7] Combined Immune Checkpoint Inhibition in an inoperable Gingival Melanoma
    Neumann, M.
    Ruppel, E.
    Unger, S.
    Zahn, A.
    Ludwig-Peitsch, Wiebke K.
    LARYNGO-RHINO-OTOLOGIE, 2020, 99 (04) : 239 - 242
  • [8] Investigation of the immune infiltrate of metastatic melanoma under immune checkpoint inhibition
    Hassel, J. C.
    Flossdorf, M.
    Haenzelmann, S.
    Winkler, J.
    Appel, L.
    Streit, E.
    Halama, N.
    Faryna, M.
    Poschke, I.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (09) : S244 - S244
  • [9] Inflammatory Blood Parameters as Biomarkers for Response to Immune Checkpoint Inhibition in Metastatic Melanoma Patients
    Kudura, Ken
    Nussbaumer, Lukas
    Foerster, Robert
    Basler, Lucas
    BIOMEDICINES, 2022, 10 (09)
  • [10] DNA methylation-based prediction of response to immune checkpoint inhibition in metastatic melanoma
    Filipski, Katharina
    Scherer, Michael
    Zeiner, Kim N.
    Bucher, Andreas
    Kleemann, Johannes
    Jurmeister, Philipp
    Hartung, Tabea, I
    Meissner, Markus
    Plate, Karl H.
    Fenton, Tim R.
    Walter, Jorn
    Tierling, Sascha
    Schilling, Bastian
    Zeiner, Pia S.
    Harter, Patrick N.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (07)
12345